Thomas was Founder, President, Chief Executive Officer and Chairman of the Board for ChemoCentryx. Thomas Schall joined Immuneering in 2024. Thomas served as Director at Immuneering.
Thomas Schall is currently
Create your alert
to follow the career of Thomas Schall.
Thomas Schall has a Bahelor of Science in Biology from Northern Illinois University and a PhD in Cancer Biology from Stanford University.
They have also studied at Northern Illinois University :
Find more alumni from Northern Illinois University
They have also studied at Stanford University :
Find more alumni from Stanford University
Do you need to know more about Thomas Schall? More results.
Report an error
Update the org chart details of Thomas Schall.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.